Insight

Sep 4, 2024, 05:57

Maria Lucia Reale: MET exon 14 skipping mutations in NSCLC

Maria Lucia Reale, Medical Oncologist at Vito Fazzi Hospital Company, shared on X:

“Just out on ESMO Open MET exon 14 skipping mutations in NSCLC RWD from the Italian biomarker ATLAS database.

Great network of colleagues and friends.”

Source: Maria Lucia Reale/X

Authors: M.L. Reale, F. Passiglia, F. Cappuzzo, G. Minuti, M. Occhipinti, A. Bulotta, A. Delmonte, C. Sini, D. Galetta, E. Roca, G. Pelizzari, D. Cortinovis, E. Gariazzo, S. Pilotto, F. Citarella, E. Bria, P. Muscolino, D. Pozzessere, A. Carta, D. Pignataro, and M. Tiseo

Maria Lucia Reale

A. Bulotta A. Carta A. Delmonte C. Sini cancer D. Cortinovis D. Galetta D. Pignataro D. Pozzessere E. Bria E. Gariazzo E. Roca ESMO Open F. Cappuzzo F. Citarella F. Passiglia G. Minuti G. Pelizzari M. Occhipinti M. Tiseo M.L. Reale Maria Lucia Reale non small cell lung cancer NSCLC OncoDaily Oncology P. Muscolino S. Pilotto

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage